Surgical Adhesives in Facial Plastic Surgery

Similar documents
BAXTER UNVEILS DESIGN ENHANCEMENTS TO FLOSEAL AND TISSEEL HEMOSTATIC AGENTS AT AORN MEETING

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP)

ARTISS PROVIDES TIME FOR THE FINISHING TOUCH. [Solutions for Sealant] Application and Benefi ts in Burn Surgery

PRODUCT MONOGRAPH ARTISS. Fibrin Sealant (Human), Vapor Heated, Solvent/Detergent Treated 4 IU (Slow Set)

Coagulation in perspective: Blood management. Objectives

SUMMARY OF PRODUCT CHARACTERISTICS

BAXTER ANNOUNCES AGREEMENT TO BROADEN PORTFOLIO OF INNOVATIVE SURGICAL PRODUCTS

After mixing 1 ml 2 ml 4 ml 10 ml Component 1: Sealer protein solution mg 1,500 KIU 2 IU

Physiology Unit 3 HEMATOLOGY

THE USE OF GLUES FOR HERNIA REPAIR RAMSEY MALULEKE, DEPARTMENT OF SURGERY, UNIVERSITY OF PRETORIA AND STEVE BIKO ACADEMIC HOSPITAL

Does Fibrin Sealant Reduce Seroma after Immediate Breast Reconstruction Utilizing a Latissimus Dorsi Myocutaneous Flap?

TISSEEL [Fibrin Sealant] For Topical Use Only Frozen solution and lyophilized powder for solution for topical application Initial U.S.

The Use of Autologous Platelet-Rich Plasma (Platelet Gel) and Autologous Platelet-Poor Plasma (Fibrin Glue) in Cosmetic Surgery

Autologous Fibrinogen Purification and Concentration For Use in Fibrin Sealant

A review of Dr. Dinakar Golla s clinical research with AdMatrix surgical grafts for soft tissue repair

Primary hemostasis. Vascular endothelium Vasoconstriction : local tissue factor, nervous system

Coagulation Mechanisms Dr. Nervana Bayoumy

A.P.A.G. Activated Plasma Albumin Gel

THROMBIN-JMI (Thrombin, Topical (Bovine) U.S.P.), Solution for topical use Initial U.S. Approval: 1986

ALLODERM SELECT ALLODERM SELECT RESTORE

Instructions for Use READY TO USE

ORIGINAL ARTICLE. The Use of Fibrin Glue in the Correction of Pollybeak Deformity

See 17 for PATIENT COUNSELING INFORMATION Revised: 01/2012 FULL PRESCRIBING INFORMATION: CONTENTS *

Xcede Technologies, Inc. Dynasil Corporation of America Annual Meeting of Stockholders. Peter Sulick, Chairman, President and CEO February 26, 2015

Introduction Hemostasis: Tourniquet Test & Bleeding Time. Hematology-Immunology System Faculty of Medicine Universitas Padjadjaran LOGO

Each 7.0 cm x 7.0 cm dressing contains 140 to 260 mg of human fibrinogen and 130 International Units of human thrombin.

Autologous Thrombin: Intraoperative Production From Whole Blood

Can Platelet-Rich Plasma Therapy Help Surgery Patients Heal Faster?

TITLE: Recombinant Human Thrombin: Clinical Effectiveness And Cost-Effectiveness

ROLE OF FIBRIN SEALANT IN PREVENTION OF HANGING PALATE OUR EXPERIENCE. Elankumar S, Chittoria R K *

General Principles of. Hemostasis. Kristine Krafts, M.D.

Hemostasis. by Mohie-Aldien Elsayed

Guideline on core SmPC for plasma-derived fibrin sealant/ haemostatic products

Comparative Study Between Fibrin Glue Prepared from a Single Human Donor and Sutures for Sealing Induced Corneal Penetrating Wounds on Porcine Eyes

Presenting SURGICEL Powder

Adv Pathophysiology Unit 4 Page 1 of 10. Learning Objectives for this file:

INSTRUCTIONS FOR USE FOR:

ADHESIVE SEALANT BIOMATERIALS

Discover TruPRP. PRP the way you want it.

Discover TruPRP. PRP the way you want it.

Get the most out of Pure PRP

Business Review Deutsche Bank Conference May 4, Gary Pruden Company Group Chairman Worldwide Franchise Chairman Ethicon

ARTISS. NAME OF THE MEDICINE Two-Component Fibrin Sealant, Deep-Frozen, Vapour Heated (VH) and Solvent Detergent (S/D) treated.

Guideline on core SmPC for plasma-derived fibrin sealant/ haemostatic products

Addressing Surgical Bleeding Situations With Adjunctive Hemostats *

LABORATORY APPROACH TO BLEEDING DISORDERS DR NISHANTH PG 1 ST YEAR DEPARTMENT OF PATHOLOGY

The Power in You. TM

Enzymatic Hydrolysis of Silk Fibroin Peptide for Hemorrhage Control

Plasma Testing in the Clinical Coagulation Laboratory: New drugs, new problems.

AUSTRALIAN PRODUCT INFORMATION ARTISS (APROTININ, FACTOR XIII, FIBRINOGEN, THROMBIN, CALCIUM CHLORIDE DIHYDRATE)

Safe Harbor Statement

Adhesive Use in Oral and Maxillofacial Surgery

Home Study Program. Intraoperative use of autologous platelet-rich and platelet-poor plasma for orthopedic surgery patients T

Surgery* a network linking collagen and glycosaminoglycans (normal components of tissue matrix) in such a way

Fibrin Glue in Skin grafts for Skin cancer (FiGSS): Open randomised clinical trial

Fixation of split thickness skin graft using fast clotting fibrin glue containing undiluted high concentration thrombin or sutures: a comparison study

Clotalyst. Autologous Activation Solution. Surgical Technique

Arthrex Angel TM System. Indication-specific PRP and PRF gel preparations

Product Information as approved by the CHMP on 15 November 2012, pending endorsement by the European Commission

Description. Used materials. Warnings and precautions

These handouts are only meant as a guide while you follow the presentation on the screen. Sometimes the speaker will change some of the slides.

D-Stat Dry Topical Hemostat Proven to Reduce Time-to-Hemostasis 1,2

Manejo de la transfusión de plaquetas. Ileana López-Plaza, MD

The Role Of Point of Care Coagulation Testing (POCCT) in Patient Blood Management. Elham Khalaf Adeli

The Clinical Use and Immunologic Impact of Thrombin in Surgery

Disclosures. Thromboelastography. TEG Methodology. TEG Output. Thromboelastography (TEG): Basics & Clinical Applications

Blood Product Utilization

Each TISSEEL Lyo contains 4 vials. The active ingredients are:

Database Review of Possible Factors Influencing Point-of-Care Platelet Gel Manufacture

2. QUALITATIVE AND QUANTITATIVE COMPOSITION. Active substances Human fibrinogen, Coagulation Factor XIII (human), Aprotinin (bovine)

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Category Storage Shelf Life Additional Criteria

31st 31 Annual Controversies, Problems a nd and and Techniques Techniques in

HEMOSTASIS IN SURGERY

PREVELEAK Surgical sealant

National Institute for Health and Care Excellence Medical Technologies Evaluation Programme

T HE DEMONSTRATION of the effectiveness of fibrin foam as an agent for

ANEMIA. Oral iron. IV iron gluconate (order set #233)

See 17 for PATIENT COUNSELING INFORMATION. Revised: 9/2017

Platelet Factor IV- Heparin Antibodies. Presenter: Michael J. Warhol, M.D.

Public Health Service DEPARTMENT OF HEALTH & HUMAN SERVICES

Section 8. To introduce the basic theory and principles of collecting blood for Intraoperative Cell Salvage (ICS)

Ch 13: Blood. What does blood do? Transport: Regulation: Protection:

Platelet Concentrate in Total Knees BIOLOGICS. This brochure is for International use only. It is not for distribution in the United States.

PRODUCT MONOGRAPH EVICEL. 2 x 1 ml, 2 x 2 ml & 2 x 5 ml Kits. Fibrin Sealant Kit Ph. Eur. Haemostatic Agent

PRODUCT MONOGRAPH EVICEL. 2 x 1 ml, 2 x 2 ml & 2 x 5 ml Kits. Fibrin Sealant Kit Ph. Eur. Haemostatic Agent

DuraGen Secure. Dural Regeneration Matrix

Product Data Sheet - TRUEMAB

New factor concentrates on the way to the market

Coagulopathy Case-2. Andy Nguyen, M.D. 2009

Histoacryl Flexible Improved closure of surgical incisions

Innovative Uses of Adhesives in Anterior Segment Surgery. Financial Disclosure

FORWARD LOOKING STATEMENT

Histoacryl A revolution in mesh fixation

Advance approaches for skin closure

María Luisa Navarrete Álvaro, 1 N. Ortiz, 1 L. Rodriguez, 2 R. Boemo, 1 J. F. Fuentes, 1 A. Mateo, 1 and P. Ortiz 2. 1.

APPLICATION OF AUTOLOGOUS PLATELET RICH PLASMA (APRP) AS AN ADJUVANT THERAPY IN PLASTIC SURGERY

PRP Preparation. Simplicity for Success

Hemostats - Medical Devices Pipeline Assessment, 2016

Product Data Sheet - TRUEMAB

Transcription:

Surgical Adhesives in Facial Plastic Surgery Dean M. Toriumi, Victor K. Chung, Quintin M. Cappelle University of Illinois at Chicago Chicago, IL Supplement to Toriumi DM, Chung VK, Cappelle QM. Surgical adhesives in facial plastic surgery. Otolaryngologic Clinics, Volume 49, Issue 3. 2016 Elsevier Inc. All rights reserved.

Why is bleeding a problem in facial plastic surgery? Skin flap injury from cautery Extended operative time Delayed wound healing Poor aesthetic outcome Return to operating room

Categories of Surgical Tissue Adhesives Cyanoacrylates Fibrin tissue adhesives

Cyanoacrylates Superficial wound closure No hemostatic property, only a tissue adhesive Elicit foreign body reaction when placed subdermally Longer chains derivatives demonstrate decreased toxicity E.g. Dermabond (Ethicon, Somerville, NJ)

Fibrin Tissue Adhesives Mechanism of action occurs on the coagulation cascade, replicating the body s natural hemostasis pathway Conversion of fibrinogen to fibrin initiates clot formation Fibrin Tissue Adhesives are composed of 2 components that activate when mixed together

Coagulation Pathway Extrinsic and Intrinsic Pathways give way to the Common Pathway The last step in the common pathway is the conversion of fibrinogen to fibrin Fibrinogen in the plasma is converted to fibrin in the presence of thrombin and calcium chloride Factor XIII catalyzes fibrin molecules to cross-link to form a clot

Fibrin Tissue Adhesive Components Component 1 Fibrinogen, calcium chloride, Factor XIII Component 2 Thrombin and anti-fibrinolytic agent Component 1 Component 2 Fibrinogen Factor XIII Calcium Chloride Anti-fibrinolytic Thrombin Fibrin Sub-units Stable Fibrin Clot

Optimal Concentrations of Thrombin Thrombin concentration is proportional to the rate of polymerization High Thrombin concentration = rapid polymerization and hemostasis >500 U/mL Low thrombin concentration = slower polymerization and time for flap manipulation 10 100 U/mL

Methods of Application Single Barrel Syringe Less uniform mixing Cumbersome Double Barrel syringe Clogging issues Gas-Pressurized Spray Requires pressurized air source Increased expense A B

Autologous Fibrin Tissue Adhesives Patient s own blood, autologous Collected pre-operatively No risk of disease transmission or immune reaction Centrifugation isolates the platelet-rich plasma layer Fibrinogen collected at a natural concentration Combined with pre-made mixture of thrombincalcium chloride Low risk of factor V cross-reactivity with bovine thrombin Selphyl device (Aesthetic Factors, LLC, Princeton, NJ)

Homologous Fibrin Tissue Adhesives Pooled donors, homologous Greater concentration of fibrinogen compared to plateletrich plasma Identical substrates of fibrinogen, thrombin, calcium chloride, Factor XIII Theoretical risks associated with homologous products (transmission of HIV and hepatitis) E.g. Tisseel and Artiss (Baxter Healthcare Corp., Deerfield, IL); Evicel (formerly Crosseel) (Omrix Biopharmaceuticals, Israel)

Risk of Viral Transmission from Homologous Products 1 reported case of B19 parvovirus transmission Risk estimated at 1:500,000 No reported cases of HIV, Hepatitis B, or Hepatitis C Risk estimated at < 1x10 15

What are the proposed benefits of fibrin tissue adhesives in facial plastic surgery? Improved hemostasis Expedited operating time Decreased edema Decreased ecchymosis Expedited postoperative recovery

FDA Off-label Use Fibrin combined with thrombin since 1944 FDA approval in 1998 Artiss (Baxter Healthcare Corp., Deerfield, IL) Adhere autologous skin grafts to surgically prepared wound beds resulting from burns in adult and pediatric populations Tisseel (Baxter Healthcare Corp., Deerfield, IL): Prevent leakage from colonic anastomoses, adjunct to hemostasis in adults and pediatric patients undergoing surgery Evicel (formerly Crosseel) (Omrix Biopharmaceuticals, Israel) Adjunct to hemostasis in patients undergoing liver surgery

A Applications in B Facial Plastic and Reconstructive Surgery Historic use 1944 first application Grafts & Flaps Obliterates dead space Promotes hemostasis C Decreases seroma formation Aids in neovascularization of graft or flap

Optimal Application Thickness Higher skin graft survival with thin application of fibrin sealant (vs. thicker application) Similar survival between thin application group and the control Decreased survival with thicker application versus the control Fibrinogen concentration did not affect skin graft survival Critical for grafts, but less important for well-vascularized flaps Thinner layer FTA Thicker FTA

Fibrin Tissue Adhesive Use in Facial Plastic Surgery: Rhytidectomy Randomized, prospective, blinded trials trend toward reduced drainage from indwelling suction drains and no effect on hematoma Retrospective (large) reduced hematoma rate in fibrin sealant group 3.4% vs 0.4%; p = 0.01 Sequential trials with unilaterally treated face: reduced both drainage and hematoma Fibrin glue reduced drainage but there was no difference in hematoma rates

Fibrin Tissue Adhesive Use in Facial Plastic Surgery: Rhytidectomy Technique: Lower thrombin concentration Skin flaps are designed and tailored Fixation sutures are placed, but not tied Pressurized spray application Skin flap is positioned Sutures are tied Pressure applied No drain placement Courtesy of Baxter; Deerfield, IL; with permission.

Fibrin Tissue Adhesive Use in Facial Plastic Surgery: Endoscopic Forehead Lift Technique Subperiosteal dissection Release of arcus marginalis Division of procerus and corrugator muscles Temporal dissection and lateral suture fixation Fixation with suture and fibrin tissue adhesive Fixation sutures are placed but not tied 2mL of homologous fibrin tissue adhesive along orbital rim and on divided muscles Normal thrombin concentration 15 cm malleable double-barrel applicator tip Fixation sutures are tied Pressure to glabella 5-10 minutes Courtesy of Baxter; Deerfield, IL; with permission.

Fibrin Tissue Adhesive Use in Facial Plastic Surgery: Selecting Cases Recommended for use in case by case basis Excess intraoperative bleeding Augmenting traditional fixation No supported role in rhinoplasty